梗阻性胰腺病的消内镜终局:顺行EUS引导胰管引流结局——一项双中心研究
本研究为双中心回顾性病历复习,纳入2016年4月至2019年9月尝试顺行EUS引导胰管引流(EUS-PDD)的28例患者(平均年龄59岁,50%女性;慢性胰腺炎93%,Whipple术后胰肠吻合口狭窄7%)。2例胰肠吻合口狭窄患者行环状引流均技术成功且临床成功100%;26例慢性胰腺炎患者尝试胰胃吻合术,技术成功81%、临床成功75%、不良事件15%,其中15例临床成功者经重复内镜透壁干预后全部实现 definitive therapy,中位随访4.5个月临床成功维持100%。
要点
- 顺行EUS-PDD是良性梗阻性胰腺病难治病例的挽救性手段。
- 胰胃吻合术(PG)建立的技术失败率19%、临床失败率25%、不良事件率15%。
- PG后技术及临床成功者经重复透壁干预可达100% definitive therapy且结局优良。
核心结论
- 顺行EUS-PDD在胰胃吻合术建立时出现轻至中度偏高的技术失败率(19%)、临床失败率(25%)和不良事件率(15%),与既往研究一致;在PG建立后技术及临床均成功的慢性胰腺炎患者(n=15)中,100%实现 definitive therapy,临床结局优良(临床成功100%,不良事件0%)。
研究设计与样本
- 双中心回顾性病历复习,纳入2016年4月至2019年9月尝试顺行EUS-PDD的28例患者(平均年龄59岁,50%女性)。
- 基础疾病为慢性胰腺炎(93%)或Whipple切除术后胰肠吻合口狭窄(7%)。
- 研究终点为实现经乳头/经吻合口的引流(definitive therapy)。
主要发现
- 2例胰肠吻合口狭窄患者于指数操作中成功行胃胰肠吻合术(环状引流,definitive therapy),技术成功100%;平均18个月随访期间临床成功100%。
- 26例慢性胰腺炎患者尝试胰胃吻合术(PG),技术成功81%、临床成功75%、不良事件15%。
- PG建立后临床成功的15例患者接受了重复内镜透壁干预,每例中位1次重复操作后全部实现 definitive therapy。
- definitive therapy后中位4.5个月随访期间,15例患者临床成功维持100%。
关键数值与推荐
- PG建立的技术失败率19%、临床失败率25%、不良事件率15%。
- PG后技术及临床均成功者(n=15)definitive therapy达100%、临床成功100%、不良事件0%。
- 2例环状引流受者平均18个月随访临床成功100%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Anterograde endoscopic ultrasound-guided pancreatic duct drainage (EUS-PDD) refers to transmural drainage of the main pancreatic duct via an endoprosthesis passed anterograde through the gastric (or intestinal) wall. Anterograde EUS-PDD is a rescue procedure for recalcitrant cases of benign obstructive pancreatopathy. METHODS: We conducted a dual-center retrospective chart review of 28 patients (mean age, 59 years; 50% female) who underwent attempted anterograde EUS-PDD between April 2016 and September 2019 for chronic pancreatitis (CP) (93%) or pancreaticojejunostomy stenosis (PJS) after Whipple resection (7%). The study endpoint was achievement of transpapillary/transanastomotic drainage (definitive therapy). RESULTS: Gastropancreaticoenterostomy (ring drainage, definitive therapy) was successfully performed during the index procedure in the 2 patients with PJS (technical success, 100%). Clinical success was 100% in the 2 ring drainage recipients during a mean 18-month follow-up period. The remaining 26 patients with CP underwent attempted pancreaticogastrostomy (PG) with 81% technical success, 75% clinical success, and 15% adverse events (AEs). Repeat endoscopic transmural interventions were performed in the 15 patients with clinical success after PG creation. Definitive therapy transpired in all 15 patients after a median 1 repeat procedure per patient. Clinical success after definitive therapy was maintained in all 15 patients (100%) during a median 4.5-month follow-up. CONCLUSIONS: In agreement with previous studies, our study showed mild to moderately high rates of technical failure (19%), clinical failure (25%), and AEs (15%) during index drainage (PG creation). Among patients with CP with both technical and clinical success after index PG creation (n = 15), 100% definitive therapy was achieved and clinical outcomes were excellent (100% clinical success, 0% AEs).
引用
- Krafft MR, Croglio MP, James TW, et al. Endoscopic endgame for obstructive pancreatopathy: outcomes of anterograde EUS-guided pancreatic duct drainage. A dual-center study. Gastrointest Endosc. 2020. PMID: 32376334. doi:10.1016/j.gie.2020.04.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。